Search PubMed⌕ Search

Biomedical subjects

A Berglund

Publications and source records attributed to A Berglund.

At least 73 records · Page 4Linked to original sources
PubMed1990

An immunoassay for histamine based on monoclonal antibodies.

Monoclonal antibodies with high specificity for histamine as well as for 1-methylhistamine were obtained after immunization of mice with a conjugate where the histamine was coupled via its ring 1-nitrogen to dog serum albumin. An immunoassay was developed for the quantitation of histamine release from basophils and 1-methylhistamine release from mast cells after provocation. The test method is based on competitive inhibition between histamine and a labelled histamine conjugate for the antigen binding sites of the antibodies. The separation step is performed by the addition of solid phase bound anti-mouse subclass specific antibodies. The sensitivity of the assay is 2 micrograms/l for histamine and 0.1 micrograms/l for 1-methylhistamine. No cross-reactivity was obtained with other metabolites of histamine or with histidine. Serotonin and dopamine were detectable, but only in doses (mg/l) well above the normal concentration found in the circulation. The immunoassay has been evaluated for its capacity to measure histamine release in vitro. A good correlation with the conventional fluorometric assay was obtained when histamine released from allergen stimulated leucocytes from allergic patients was tested. Urinary samples from patients undergoing hyposensitization showed a mean excretion of 1-methylhistamine at a level of 131 mumol MeHi/mol creatinine. The release of histamine and 1-methylhistamine in vivo was examined in plasma samples taken during a bronchial provocation test. A significant elevation above the basal analyte level occurred ten minutes after provocation.

Animals↗
PubMed1990

Hip fractures in women with breast cancer.

The authors investigated whether the incidence of first hip fracture, an indicator of osteoporosis, is lower in breast cancer patients, who are assumed to have higher levels of endogenous estrogens, than in other women. A population-based Swedish cohort comprising 9,673 women with invasive breast cancer diagnosed from 1958 through 1983 was followed up with respect to the occurrence of a first hip fracture during the period 1965-1983. Overall, the number of observed acute fractures (n = 387) was slightly higher than expected (n = 348.6) (standardized incidence ratio (SIR) = 1.1, 95% confidence interval (CI) 1.0-1.2). Risk for trochanteric fractures was slightly higher than expected (SIR = 1.2, 95% CI 1.0-1.4), but risk for cervical fractures was not (SIR = 1.0, 95% CI 0.9-1.1). Risk for trochanteric fracture decreased with increasing age at breast cancer diagnosis, reaching standardized incidence ratios close to unity after the age of 70 years. Duration of follow-up appeared to be unrelated to the risk of either type of fracture. The authors conclude that the incidence of first hip fracture is not lower in breast cancer patients than in other women.

Adult↗
PubMed1990

Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.

In a double-blind, randomized, cross-over study with a single-blind placebo run-in period a new controlled-release (CR) formulation of metoprolol 200 mg once daily was compared with atenolol tablets 100 mg once daily in 22 patients (age 60.9 +/- 0.93 (SE) years) with primary hypertension and impaired or diabetic glucose tolerance. Each period lasted for three weeks. The two agents produced similar blood pressure 3 h as well as 24 h after drug intake. Three hours after drug intake, heart rate was lower on atenolol than metoprolol CR treatment, indicating a higher degree of beta-receptor blockade for atenolol at this point in time, when the plasma concentration of atenolol was most likely to be close to its peak. Concentrations of blood glucose, serum insulin, and serum C-peptide in the fasting state or after an oral glucose load did not differ between the active agents. HbA1c was marginally, but significantly, lower on atenolol than metoprolol CR treatment. No differences were found in serum levels of total, low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol or apoA-I, and apoB lipoproteins or triglycerides. In comparison to the placebo run-in period, both agents showed an unexpected improvement in glucose tolerance, a decrease in HDL cholesterol and for metoprolol CR a small, but significant decrease in LDL cholesterol. Thus, treatment with metoprolol CR tablets producing even plasma levels without high peak concentrations and conventional atenolol treatment had similar effects on metabolic control in hypertensive men and abnormal glucose tolerance.

Aged↗
PubMed1990

Estimation by a 24-hour study of the daily dose of intra-oral mercury vapor inhaled after release from dental amalgam.

The difficulties associated with estimations of daily doses of inhaled mercury vapor released from dental amalgam are considerable. Existing data are often unreliable, especially if they are based on a single or a small series of samples of intra-oral concentrations of mercury vapor before, during, and after chewing stimulation. In the present paper, the aim was to obtain a more representative estimation of the daily dose of mercury vapor inhaled from amalgam fillings by measurement of amounts of mercury vapor released in the oral cavity during 24 h, under conditions that were as normal as possible. A series of measurements was carried out on each of 15 subjects, with at least nine occlusal surfaces restored with dental amalgam, and on five subjects without any amalgam restorations. The subjects had to follow a standardized schedule for 24 h, whereby they ate, drank, and brushed their teeth at pre-determined time periods. The amount of mercury vapor released per time unit was measured at intervals of 30-45 min by means of a measuring system based on atomic absorption spectrophotometry. None of the subjects was professionally exposed to mercury, and all of their amalgam fillings were more than one year old. Study casts were made for each subject, and the area of the amalgam surfaces was measured. Samples of urine and saliva were analyzed so that values for the mercury concentrations and the rate of release of mercury into saliva could be obtained. The average frequency of fish meals per month was noted.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1989

Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.

OBJECTIVE: To determine whether dietary treatment has a similar antihypertensive effect to conventional drug treatment while being superior to drugs in improving serum lipid concentrations in obese men with mild hypertension. DESIGN: Six week run in period followed by randomisation to either diet or drug treatment groups for one year. SETTING: Outpatient clinic in city hospital. PATIENTS: 61 Men aged 40-69 years, body mass index greater than or equal to 26, diastolic blood pressure 90-104 mm Hg when untreated. Exclusion criteria were signs of organ damage secondary to hypertension and diseases that might have interfered with compliance or with interpretation of results. INTERVENTIONS: Dietary treatment was based on weight reduction, restriction of sodium, and decrease of excess alcohol intake (defined as greater than or equal to 250 g alcohol per week). Drug treatment used a stepped care approach with atenolol as drug of first choice. MAIN OUTCOME MEASURES: Diastolic blood pressure less than 90 mm Hg; absolute reductions in blood pressure and serum lipid concentrations. RESULTS: Mean body weight decreased 7.6 kg in the diet group and increased 0.9 kg in the drug treatment group (p less than 0.0001), and mean sodium excretion decreased 42 and 10 mmol/24 h respectively (p = 0.019). There was no difference in reported alcohol intake. Mean systolic blood pressure decreased 4 mm Hg in the diet group and 16 mm Hg in the drug group (p = 0.003) and diastolic blood pressure 3 and 11 mm Hg respectively (p = 0.002). Diastolic blood pressure of 90 mm Hg was attained by 29% of the diet group (nine men) and 73% (22) of those receiving drug treatment (mean difference 44%, 95% confidence interval 21 to 67%, p = 0.001). Dietary treatment produced decreases in mean serum concentrations of total and low density lipoprotein cholesterol as well as triglycerides and an increase in high density lipoprotein cholesterol concentration. In the drug treatment group the changes were in the opposite direction, and the groups differed significantly in all but total cholesterol. CONCLUSIONS: Dietary treatment was inferior to conventional drug treatment in controlling mild hypertension but superior in lowering serum concentrations of lipids.

Adult↗
PubMed1989

Model of mercury vapor transport from amalgam restorations in the oral cavity.

A model of the oral cavity was used as the basis for a discussion of the conditions prevalent during the transport of mercury vapor from amalgam restorations via the saliva to the gas phase of the oral cavity during respiration or during pumping of air through the mouth. It was found that the mercury diffusion rate through the saliva layer is independent of the air flow rate through the oral cavity. Mercury appears to be transported as atoms both in the aqueous phase of saliva and in the gas phase. The majority of the mercury atoms reaching the gas phase appears to originate directly from the surface of the amalgam restorations, passing through the saliva layer, while only a minority originates from mercury dissolved in the aqueous phase. The amount of mercury released per unit of time to the gas phase was shown to be independent of the air flow rate during respiration and pumping. Furthermore, the released mercury atoms are distributed partly to the gas phase, from which they are respired to the lungs and the environment, and partly to the saliva and the gastro-intestinal tract, by swallowing.

Dental Amalgam↗
PubMed1988

Influence of calmodulin on the human red cell membrane skeleton.

The calcium receptor calmodulin interacts with components of the human red cell membrane skeleton as well as with the membrane. Under physiological salt conditions, calmodulin has a calcium-dependent affinity for spectrin, one of the major components of the membrane skeleton. It is apparent from our results that calmodulin inhibits the ability of erythrocyte spectrin (when preincubated with filamentous actin) to create nucleation centers and thereby to seed actin polymerization. The gelation of filamentous actin induced by spectrin tetramers is also inhibited by calmodulin. The inhibition is calcium dependent and decreases with increasing pH, similar to the binding of calmodulin to spectrin. Direct binding studies using aqueous two-phase partition indicate that calmodulin interferes with the binding of actin to spectrin. Even in the presence of protein 4.1, which is believed to stabilize the ternary complex, calmodulin has an inhibitory effect. Since calmodulin also inhibits the corresponding activities of brain spectrin (fodrin), it appears likely that calmodulin may modulate the organization of cytoskeletons containing actin and spectrin or spectrin analogues.

Actins↗
PubMed1988

Determination of the rate of release of intra-oral mercury vapor from amalgam.

The experimental and analytical difficulties associated with the measurement of mercury vapor in the oral cavity are considerable. In the present paper, the objective was to measure the amount of intra-oral mercury vapor in subjects with amalgams, by means of two sets of equipment based on different functional principles. In addition, it was found that the type of mercury source prevalent in the oral cavity had to be evaluated. The measuring technique used to obtain correct results is discussed, and an evaluation of the conditions for the application of the measuring equipment available was made. It was found that the amount of mercury released from the oral cavity was time-dependent. Furthermore, the amount of mercury released with the time kept constant was almost independent of the pumping flow rate up to 8 L/min. It was found that the tissue, saliva, and the amalgam restorations were not depleted of mercury during the measuring time. The results of the Mercollector-Mercometer measurements carried out on seven subjects with nine or more occlusal surfaces restored with dental amalgam and on three subjects without any amalgam restorations revealed that the rate of mercury release was in the range 0.03-0.34 ng/sec in the former group and less than 0.01 ng/sec in the latter. Based on the experimental results and on theoretical considerations, it was concluded that the amount of mercury released per time unit is the only quantity measurable.

Adult↗
PubMed1988

A new instrument for mercury vapor evacuation during clinical work with dental amalgam.

Clinical work with dental amalgam, cutting as well as filling and polishing operations, results in an increased level of mercury vapor in the breathing zone of the patient and often also in that of the dentist. The mercury levels can be minimized by the use of a high volume evacuator which is handled by the nurse. Since many dentists cannot count upon continuous chairside assistance during work with dental amalgam a new instrument, combining the functions of a common dental mirror and an evacuator has been developed. The aim of the present work was to evaluate the mercury vapor evacuating capacity of the new instrument. The study was carried out in a model box especially designed for the in vitro tests performed. The amount of mercury in an area representing the patient's breathing zone was recorded directly and indirectly using an equipment based on atomic absorption spectrophotometry. The results revealed that the new instrument has the capacity for substantially reducing the mercury levels during filling, polishing and cutting amalgam. Thereby the short transitory exposure to mercury vapor during certain working moments can be reduced which should be beneficial both to the patient and to the dental staff.

Air Pollutants, Occupational↗
PubMed1986

The 240-kDa subunit of human erythrocyte spectrin binds calmodulin at micromolar calcium concentrations.

The binding of the isolated alpha-subunit of human erythrocyte spectrin to calmodulin is demonstrated by partitioning in aqueous two-phase systems. The affinity of the alpha-subunit for calmodulin is slightly higher than that of the spectrin dimer, whereas the beta-subunit interacts only very weakly. The binding is in all cases calcium-dependent and is abolished on addition of chlorpromazine. At an ionic strength close to physiological conditions, about 1 microM free calcium is required to induce maximum binding of calmodulin to spectrin dimer.

Calcium↗
PubMed1984

Calmodulin binding to human spectrin.

Calmodulin is shown to interact with human spectrin dimer. The binding was highly calcium-dependent and observed in two different kinds of experiments. Firstly, affinity chromatography of calmodulin on a Sepharose 4B column with immobilized spectrin, and secondly, partition in aqueous two-phase polymer systems. In the column experiments stoichiometric amounts of calmodulin were retained on the spectrin-Sepharose column when micromolar concentrations of calcium were present. The calmodulin bound could be eluted with EGTA. The partition coefficient of calmodulin in an aqueous two-phase polymer system containing calcium was changed upon addition of spectrin, indicating an association between the two proteins. In the absence of calcium, spectrin did not cause any change in the partition behaviour of calmodulin, thus showing that the association requires calcium.

Animals↗
PubMed1983

A monoclonal antibody-enzyme immunoassay for serum carcinoembryonic antigen with increased specificity for carcinomas.

A two-site monoclonal antibody-enzyme immunoassay (MEIA) for carcinoembryonic antigen (CEA) was developed that uses two monoclonal anti-CEA antibodies, which recognize two different epitopes in the peptide moiety of CEA. The assay was sensitive to 0.5 micrograms/liter and had a measuring range of 0.5-200 micrograms of CEA per liter. It was highly specific inasmuch as none of three known CEA-related substances, "nonspecific crossreacting antigens 1 and 2" (NCA-1 and NCA-2) and biliary glycoprotein I (BGP I), reacted in the assay. NCA-2 (meconium antigen) is very similar to CEA. None of five commercially available CEA assays were able to differentiate between CEA and NCA-2. With one exception (colon), normal tissue extracts did not react in the MEIA even when tested at very high concentrations. Sera from a total of 180 healthy individuals and patients with malignant and nonmalignant disease were analyzed for CEA levels by using the MEIA and in parallel a conventional radioimmunoassay. A significant increase in specificity for carcinomas was obtained with the MEIA. This was essentially due to a decrease of MEIA CEA values in sera from patients with nonmalignant disease. The CEA values in the group of carcinoma patients (colon, pancreas, lung, and breast) were the same in the two assays.

Antibodies, Monoclonal↗
PubMed1983

Effects of different injurious stimuli on cell death, proliferation, and collagen secretion by rabbit aortic smooth muscle cells and human umbilical vein endothelial cells in culture.

Rabbit aortic smooth muscle cells were exposed to hypoxia and the DMSO-soluble particulate matter of cigarette smoke (DSP) and the effects on the cells were compared to those of ultraviolet (UV) light, a wellknown cytotoxic stimulus. Hypoxia reduced cell proliferation and collagen secretion as long as it lasted (1, 3 and 24 hours), but these effects were reversible and no persistent toxic effects were seen for the next 48 hours, measured as leakage of prelabelled [3H]-thymidine from cells. DSP caused similar changes to those produced by UV-light. Proliferation and collagen secretion were reduced, and these effects were not reversible when the stimulus was removed after one hour. DSP was toxic as there was an increased leakage of [3H]-thymidine from cells. Increasing the concentration of DSP caused more pronounced effects while extending the incubation time to 3 hours did not, the latter being in contrast to the consequences of UV-irradiation. Endothelial cells were more sensitive to the effects of DSP than smooth muscle cells. DSP diluted 1:25 compared to the smallest concentration that had significant effects on smooth muscle cells reduced proliferation of endothelial cells, and in dilutions of 1:4 almost all of the cells detached. A possible role for DSP in the development of atherosclerosis is discussed.

Animals↗
PubMed1981

Radioallergosorbent test with conjugates specific for 'minor' haptenic determinants in the diagnosis of IgE-mediated penicillin allergy in man.

Penicillamine-polylysine, benzylpenicillanyl-human serum albumin and ampicillin-polymers were coupled to CNBr-activated paper discs and used in addition to penicilloyl G and penicilloyl V discs in RAST investigations. Sera from sixty patients with case histories of penicillin allergy and with positive or negative skin tests to different penicillin determinants and from seventeen subjects with atopic diseases caused by allergens other than penicillin were tested. The penicilloyl-('major' determinant) specific RAST (Phadebas RAST Penicilloyl G and V) was positive in twenty out of twenty-four patients with positive skin tests to penicilloyl-polylysine, in eight out of twelve patients with sole skin reactivity to 'minor' determinants, and in five out of twenty-four patients with negative skin tests to all antigens used. The penicillamine-specific RAST was the only positive in vitro test in four patients with negative skin tests (two) or sole positive skin reactivity to 'minor' determinants (two), whereas benzylpenicillanyl and ampicillin-polymer discs added no more information than the penicilloyl structures in all patients tested. Antibodies specific to 'minor' determinants apparently show strong in vitro cross-reactivity with the penicilloyl determinant. It is, therefore, concluded that 'minor' determinant specific conjugates are of marginal importance for in vitro diagnosis of penicillin-allergic patients.

Benzeneacetamides↗
PubMed1979

IgE antibodies against penicillin as determined by Phadebas RAST.

Serum samples from eighty-one patients with suspected penicillin allergy were investigated with Phadebas RAST using the penicillin derivatives Benzylpenicilloyl-human serum albumin (PBO-HSA) and Phenoxymethylpenicilloyl-human serum albumin (PMPO-HSA) and the results were compared with skin test results and clinical data. Of the sixty-one patients who had anaphylactic shock and/or urticaria as a possible consequence of penicillin administration, reagins against PBO-HAS and PMPO-HSA could be detected in thirty-four cases (56%). Five per cent of these patients, with positive RAST results, showed negative skin tests; in the other 95% both RAST and skin tests were positive. All, except eight, of the RAST-negative patients had had their adverse reactions at least 2 years prior to the blood sampling and in some of these cases skin tests were also negative. RAST and provocation test results agreed in 80% of the cases where exposition was performed. It is concluded that the RAST technique is a valuable diagnostic tool for the detection of immediate type hypersensitivity to penicillin.

Anaphylaxis↗